Search Results
Results found for "Dopamine receptor D3"
- Sponsorship Prospectus for Adhesion GPCR Workshop 2024 | Dr. GPCR Ecosystem
Workshop 2024, a premier scientific meeting bringing together leaders and innovators in G Protein-Coupled Receptor discussions, workshops, and networking sessions covering the latest advancements and challenges in Membrane Receptor Additional Sponsorship Opportunities: Networking Reception Sponsorship Conference Cup and T-Shirt Sponsorship
- GPCR Retreat 2023 | Dr. GPCR Ecosystem
are pleased to welcome you at Le Château Montebello , the 22nd Annual Great Lakes G Protein-Coupled Receptor Retreat held jointly with the Club des Récepteurs à Sept Domaines Transmembranaires du Québec. University of North Carolina at Chapel Hill, unquestionably one of the pioneers involved in deciphering how receptor Sincerely , The Organizing Committee Great Lakes GPCR Retreat and Club des Récepteurs à Sept Domaines
- Dr. Steven Foord | Dr. GPCR Ecosystem
identification of RAMPs (solving some CGRP family issues) and the GABA B, carboxylic, and nicotinic acid receptors
- Tanishka S. Saraf | Dr. GPCR Ecosystem
Saraf " My research focuses on evaluating and targeting serotonin 1A receptors for therapeutic outcomes
- Dr. Graciela Pineyro | Dr. GPCR Ecosystem
She has done extensive work on the molecular pharmacology of opioid receptors and is currently focusing
- Martin Audet | Dr. GPCR Ecosystem
Pharmacology of Sherbrooke and is an emerging leader in the structural biology of G Protein-Coupled Receptors
- Empowering Drug Discovery for the GPCR Community with Dr. Justin English | Dr. GPCR Ecosystem
innovating technologies to solve broad questions in pharmacology, with a specific focus on G-protein coupled receptor
- Robert Laprairie | Dr. GPCR Ecosystem
The focus of his research is the molecular pharmacology of cannabinoids and cannabinoid receptors.
- How GPCR Spatial Signaling Sparked a Scientific Journey | Dr. GPCR Ecosystem
a leadership role at the forefront of GPCR spatial signaling — a field reshaping how we understand receptor
- G Proteins and GPCRs in Cancer: Novel Precision Targeted and Immunotherapies
His research team has pioneered the study of G proteins and G protein coupled receptors (GPCRs) in human GPCR Previous Event Next Event Great Lakes GPCR Retreat and Club des Récepteurs à Sept Domaines Transmembranaires du Québec Great Lakes GPCR Retreat and Club des Récepteurs à Sept Domaines Transmembranaires du Québec
- Developing a PROTAC to Degrade the Constitutively Active Onco-GPCR in Uveal Melanoma
laboratory at Rockefeller University, where she studies the signaling and degradation of G protein-coupled receptors GPCR Previous Event Next Event Great Lakes GPCR Retreat and Club des Récepteurs à Sept Domaines Transmembranaires du Québec Great Lakes GPCR Retreat and Club des Récepteurs à Sept Domaines Transmembranaires du Québec
- Julia Gardner | Dr. GPCR Ecosystem
Julia studies the mechanisms of 'biased signaling' at GPCRs, with a specific focus on the chemokine receptor
- irreversible drugs post 3 | Dr. GPCR Ecosystem
Published on October 27, 2025 Category Terry's Corner Receptor pharmacology has evolved.
- irreversible drugs post 2 | Dr. GPCR Ecosystem
That’s why a compound like phenoxybenzamine can knock down receptor populations after just a brief exposure
- Dr. Antonella Di Pizio | Dr. GPCR Ecosystem
Today, Antonella has expanded her research to olfactory GPCRs and trace amine receptors.
- Dr. Kari Johnson | Dr. GPCR Ecosystem
career, the recurring theme in Kari’s work has been GPCRs and more specifically Metabotropic Glutamate Receptors
- Dr. David Sykes | Dr. GPCR Ecosystem
designed to assess the kinetics of unlabelled compounds (and chemical fragments) and the use of purified receptor
- Dr. Pierre Eftekhari | Dr. GPCR Ecosystem
The majority of my research is concentrated on rhodopsin family with a few works on metabotropic receptor
- Dr. John Streicher | Dr. GPCR Ecosystem
John and his team focus on understanding how signal transduction cascades downstream of the opioid receptors
- Dr. Terry Kenakin | Dr. GPCR Ecosystem
His interests are in receptor pharmacology, allosteric protein function, and drug discovery. Dr.
- Dr. Demet Araç | Dr. GPCR Ecosystem
backgrounds, and career paths, with a focus on their experiences in the field of GPCR (G protein-coupled receptor Demet's research on the gain domain of adhesion GPCRs started during his postdoctoral studies and continued Scientists Demet and Yamina discussed the progress of their research in the GPCR (G protein-coupled receptor They also discussed the importance of the extracellular region of these receptors and its potential as
- Model. Predict. Discover. with Dr. Jens Carlsson | Dr. GPCR Ecosystem
Matters Computational models are moving beyond interpretation into real-world prediction of ligand-receptor His team focuses on understanding how ligands modulate receptor function and how those insights can drive
- Dr. Brian Bender | Dr. GPCR Ecosystem
large compound libraries with the goal of finding new chemical matter to probe understudied and orphan receptors
- GPCR Courses
Practical Assessment of Signaling Bias Signaling bias is an inherent feature of pharmacology, influencing receptor Different ligands stabilize distinct receptor states, leading to diverse signaling outcomes. an educational platform that provides in-depth learning and training resources on G protein-coupled receptors
- Dr. Graham Ladds | Dr. GPCR Ecosystem
In 2020, he was promoted to a Readership/Professor in Receptor Pharmacology and was elected a Fellow
- Dr. Yamina Berchiche | Dr. GPCR Ecosystem
During the past 2 decades, my research mainly focused on chemokine receptor structure/function relationships
- Dr. Bryan Roth | Dr. GPCR Ecosystem
Bryan got fascinated with receptors after attending the lecture of a visiting professor on neurotransmission
- The Role of Quantitative Sciences in GPCRs with Dr. Nagarajan Vaidehi | Dr. GPCR Ecosystem
constrained molecular dynamics simulation methods with emphasis on application to G-protein coupled receptors
- Dr. Paul J. Gasser | Dr. GPCR Ecosystem
is currently focused on understanding the signal transduction pathways activated by beta-adrenergic receptors
- Dr. Benjamin Myers | Dr. GPCR Ecosystem
His group studies the unusual signaling mechanisms employed by these atypical 7-transmembrane receptors

























